Enlivex Therapeutics Ltd. - Share Issue/Capital Change 2019

_________ false


	Israel Securities Authority			Tel Aviv Stock Exchange		C310 ( Public )		Reported via MAGNA:	17/07/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-073408	Time of broadcast: 12:40 12:28:36

Initial Details of the Corporation�s Securities and the Corporation�s Capital

As of the date of this report, the share capital of the corporation is as follows:1


Class of share:	��

Registered capital: 18,000,000

Issued capital: 45,000,000


Currency: NIS	_________

Stock exchange on which securities are listed for trade: NASDAQ CM

Number of securities on stock exchange: 10113707

The following are details of additional securities that were issued by the corporation:1


Class of security:	_________

Series: _________


Period of conversion / realization (if aplicable):	_________


The stock exchange on which the security is listed for trade:	_________

Number of security on the stock exchange: _________

Type of shares that will derive from realization / conversion of the security (if aplicable): _________

Quantity of shares that will derive from full realization / conversion (if aplicable): _________

Number on the stock exchange of the share derive from realization / conversion of the security (if aplicable): _________



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 25/06/2019
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: [email protected] Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: [email protected] 2
ISRAEL

AI assistant